Clinical trial
Efficacy and Safety of Zolmitriptan by Sublingual Administration in the Treatment of Cluster Headache: A Multi-center Randomized Cross-controlled Trial
NCT03377257 is registered in ClinicalTrials.gov with Xijing Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety of Zolmitriptan by Sublingual Administration in the Treatment of Cluster Headache: A Multi-center Randomized Cross-controlled Trial
- Lead sponsor
- Xijing Hospital
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- January 1, 2018
- Completion date
- April 30, 2019
- Enrollment
- 71 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.